ARCHIVES

In a letter, ASCO reaffirms its views on oncology consolidation at FDA.

This article is from The Cancer Letter archive.

Vol. 30 No. 28 | July 9, 2004

Download PDF Visit The Full Archive

Related Articles

Sixty CCOPs Could cost $16 Million; DCPC Staff Believes They Can Get It

October 10, 1986

In Brief: NCAB To Hear NCOG Appeal; FDA Renege On New Toxicology Protocol, Holds Up INDs

April 24, 1981

NCCS Networker Volume 2 Issue 2, Spring 1988

April 13, 1988

Xeloda As Effective As 5-FU/LV, Five-Year Survival Data Show

September 28, 2007

ACS Picks Up Study Of tobacco Industry Influence On Voting By State Legislators

May 3, 1996

Extent Of Risk Reduction From Ovary Removal Varies According To BRCA Mutation

February 29, 2008